Chet R. Villa, MD
- Pediatric Cardiologist, Heart Failure & Transplantation
- Associate Professor, UC Department of Pediatrics
- chet.villa@cchmc.org
- Board Certified
About
Biography
Children with severe heart disease once had few clinical options. While we’ve made many advances, it’s still critical that we improve therapeutic options and develop new approaches.
At Cincinnati Children’s, I care for children with complex medical needs and severe heart disease. This includes children with Duchenne muscular dystrophy, RASopathies, and those in need of ventricular assist device therapy and heart transplant.
My research is focused on finding ways to provide care to children and young adults with heart disease who have limited access to advanced therapies.
MD: University of Cincinnati College of Medicine, Cincinnati, OH, 2007.
Residency: Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH.
Certification: American Board of Pediatrics, 2010; Pediatric Cardiology, 2014.
Interests
Advanced heart failure; heart transplantation; cardiomyopathy; mechanical circulatory support
Services and Specialties
Cardiomyopathy, Rasopathy, Cardio-Oncology, Neuromuscular Cardiology, Neuromuscular Disorders
Interests
Ventricular assist device therapy; Duchenne muscular dystrophy
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
The Creation of a Pediatric Health Care Learning Network: The ACTION Quality Improvement Collaborative. American Society for Artificial Internal Organs (ASAIO) Platinum 70th Anniversary Special Edition. : Taylor & Francis; Taylor & Francis; 2024.
Wireless Pulmonary Artery Pressure Monitor Implantation in a Patient with Duchenne Muscular Dystrophy. Pediatric Cardiology. 2024; 45:1151-1153.
Induced pluripotent stem cell (iPSC) modeling validates reduced GBE1 enzyme activity due to a novel variant, p.Ile694Asn, found in a patient with suspected glycogen storage disease IV. Molecular Genetics and Metabolism Reports. 2024; 39:101069.
In the era of outpatient ventricular assist devices, is it time to reconsider the practice of bridging older children to transplant on outpatient inotropes?. Journal of Thoracic and Cardiovascular Surgery. 2024; 167:2206-2214.
Cardiac atrial pathology in Duchenne muscular dystrophy. Muscle and Nerve. 2024; 69:572-579.
Modifiable risk factor reduction for pediatric ventricular assist devices and the influence of persistent modifiable risk factors at transplant. Journal of Thoracic and Cardiovascular Surgery. 2024; 167:1556-1563.e2.
Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies - Developing Potential Treatments for the Entire Spectrum of Disease. Journal of Neuromuscular Diseases. 2024; 11:499-523.
School age and adolescent heart failure following the Norwood procedure. The Journal of Heart and Lung Transplantation. 2024; 43:453-460.
Multicenter outcomes for ventricular assist device support for failed stage II palliation. 2024; 3:100015.
Device Innovations in Pediatric Heart Failure. Current treatment options in pediatrics. 2023; 9:273-283.
From the Blog
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2024 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey